Blog

The INDIGO project, coordinated by AIGHD, has begun its phase 1 trial of a novel low-dose influenza vaccine that combines 1/5th of a dose of a licensed influenza vaccine with a new adjuvant, an ingredient used in several vaccines to help create a stronger immune...

1,440,000 seconds. 24000 hours. 1000 days. From conception to our second birthday. After almost 25 years of research, it is this period that AIGHD Senior Fellow, Dr. Tessa Roseboom, Professor of Early Development and Health has identified as the most critical to shaping who we...

Earlier this month, we sat down with Prof. Tobias Rinke de Wit, Director of Research PharmAccess, molecular biologist, public health specialist and Senior Fellow at AIGHD, to discuss his pioneering work in digitalizing diagnostics in Africa: ‘Connected Diagnostics’. ‘Connected Diagnostics’ refers to digitalizing rapid point-of-care diagnosis...